Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target

481 indexed citations

Abstract

loading...

About

This paper, published in 2018, received 481 indexed citations. Written by Manuel H. Janeiro, María Luisa Ramírez Ramírez, Fermı́n I. Milagro, J. Alfredo Martínéz and Maite Solas covering the research area of Molecular Biology, Physiology and Public Health, Environmental and Occupational Health. It is primarily cited by scholars working on Molecular Biology (305 citations), Physiology (208 citations) and Public Health, Environmental and Occupational Health (76 citations). Published in Nutrients.

Countries where authors are citing Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target

Specialization
Citations

This map shows the geographic impact of Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target more than expected).

Fields of papers citing Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.3390/nu10101398.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial Breakdown of academic impact, for the paper Gastric cancer: a comprehensive review of current and future treatment strategies Breakdown of academic impact, for the paper Reasoning, learning, and action : individual and organizational Breakdown of academic impact, for the paper Chitosan nanoparticles preparation and applications Breakdown of academic impact, for the paper Burden of Cardiovascular Diseases in China, 1990-2016 Breakdown of academic impact, for the paper Stochastic First- and Zeroth-Order Methods for Nonconvex Stochastic Programming Breakdown of academic impact, for the paper Kinetic Theory of Granular Gases Breakdown of academic impact, for the paper Ramulator: A Fast and Extensible DRAM Simulator Breakdown of academic impact, for the paper Polyvinyl alcohol: A review of research status and use of polyvinyl alcohol based nanocomposites Breakdown of academic impact, for the paper Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Rankless by CCL
2026